BOTHELL, Wash. and TOKYO, March 28, 2019 /PRNewswire/ — Seattle Genetics, Inc. (Nasdaq: SGEN) and Astellas Pharma Inc. (TSE: 4503,
Continue reading »
Home ยป
Sunovion Announces Positive Top-Line Results from Pivotal Study Evaluating Dasotraline in Adults with Binge Eating Disorder
MARLBOROUGH, Mass.–(BUSINESS WIRE) July 25, 2018 –Sunovion Pharmaceuticals Inc. (Sunovion) today announced that a study (SEP360-321 ) evaluating the efficacy
Continue reading »
Rhythm Pharmaceuticals Completes Pivotal Enrollment in Two Ongoing Phase 3 Clinical Trials Evaluating Setmelanotide in Rare Genetic Disorders of Obesity
BOSTON, June 14, 2018 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization
Continue reading »